Scientists test new Drug's safety with common meds
NCT ID NCT07341672
Summary
This early-stage study aims to understand how three common medications (itraconazole, fluconazole, and efavirenz) affect the way the body processes a single dose of an experimental drug called clifutinib. It will enroll 80 healthy adults to measure drug levels in the blood and check for safety. The goal is to gather basic information to guide future studies, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.